The past twelve months were a year like no other for Harvard and the world. Under the backdrop of a once-in-a-century pandemic, students took classes from all over the globe, while pushing for social change at the University and on the political stage. Here, The Crimson reviews ten stories that defined 2020 at Harvard.
Legal experts say recent court filings indicate University Professor Charles M. Lieber — charged with lying to federal officials investigating his funding sources and ties to China — may try to convince jurors that Lieber was swept up in the Trump administration’s broader anti-China campaign.
Harvard filed an opposition Thursday in response to Chemistry professor Charles M. Lieber’s lawsuit alleging Harvard is contractually obligated to pay for his legal defense against federal fraud charges.
The Waterman Award recognizes researchers under age 40 “who demonstrate exceptional individual achievements in scientific or engineering research in NSF-supported fields,” according to the NSF. Awardees each receive 1 million dollars to support research in their field.
Harvard researchers uncovered the surprising role of light in ultra-cold chemical reactions, according to an article published last month in the scientific journal Nature Physics.
Federal authorities charged former Harvard Chemistry chair Charles M. Lieber in a superseding indictment with tax offenses for failing to report income he received from Wuhan University of Technology, the Department of Justice announced Tuesday.
Former Harvard Chemistry department chair Charles M. Lieber pleaded not guilty Tuesday to charges that he lied to federal investigators about research funding he received from China.
As Coronavirus Spreads, False Theories Linking Harvard Professor Lieber to Disease’s Origin Proliferate Online
As the novel coronavirus spreads, conspiracy theories about its origin have spread with it — including those falsely alleging that the virus was made and sold by Harvard Chemistry professor Charles M. Lieber.
Senator Marco Rubio Urges Small Business Administration to Re-Examine Grant Policies in Wake of Lieber Arrest
In the wake of Harvard Chemistry department chair Charles M. Lieber’s arrest, United States Senator Marco Rubio (R-Fla.) urged the U.S. Small Business Association in February to ensure recipients of its grant programs do not have connections to governments such as China.
In the wake of federal charges brought against Chemistry department chair Charles M. Lieber for failing to disclose funding from a Chinese university, University President Lawrence S. Bacow said in an interview Monday that Harvard relies upon the “honesty and good faith” of its faculty to disclose external funding.
Dean of the Faculty of Arts and Sciences Claudine Gay announced the replacements for chemistry department chair Charles M. Lieber at a faculty meeting Tuesday. Lieber was placed on administrative leave last week after being charged in federal court with failing to disclose funding from the Chinese government.
Lieber’s arrest marked merely the latest development in an ongoing crackdown by the United States government and American universities on “academic espionage,” the process by which scientists pass academic research at American universities to foreign governments.
A federal judge set bail for Harvard Chemistry department chair Charles M. Lieber — who is charged with concealing funding he received from the Chinese government — at $1 million cash in a hearing Thursday afternoon.
Chemistry department chair Charles M. Lieber has been charged in federal court with failing to disclose funding from the Chinese government, according to a criminal complaint unsealed Tuesday.
A team of Harvard chemists has succeeded in performing the coldest chemical reaction to ever occur, according to a Nov. 29 paper they published in the peer-reviewed academic journal Science.
A former Harvard post-doctoral researcher is suing a chemistry professor whose lab he worked in, alleging that the professor unfairly excluded him from a potentially lucrative cancer treatment patent.
After a federal judge allowed two claims to move forward last month in a multimillion-dollar patent royalties lawsuit filed against Harvard by a former graduate student, both parties filed statements on Monday, highlighting sharp, unresolved divides on issues of liability and relief.